Correlation Between Collplant Biotechnologies and Can Fite

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Collplant Biotechnologies and Can Fite at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Collplant Biotechnologies and Can Fite into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Collplant Biotechnologies and Can Fite Biopharma, you can compare the effects of market volatilities on Collplant Biotechnologies and Can Fite and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Collplant Biotechnologies with a short position of Can Fite. Check out your portfolio center. Please also check ongoing floating volatility patterns of Collplant Biotechnologies and Can Fite.

Diversification Opportunities for Collplant Biotechnologies and Can Fite

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between Collplant and Can is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Collplant Biotechnologies and Can Fite Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Can Fite Biopharma and Collplant Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Collplant Biotechnologies are associated (or correlated) with Can Fite. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Can Fite Biopharma has no effect on the direction of Collplant Biotechnologies i.e., Collplant Biotechnologies and Can Fite go up and down completely randomly.

Pair Corralation between Collplant Biotechnologies and Can Fite

Given the investment horizon of 90 days Collplant Biotechnologies is expected to generate 1.1 times more return on investment than Can Fite. However, Collplant Biotechnologies is 1.1 times more volatile than Can Fite Biopharma. It trades about 0.3 of its potential returns per unit of risk. Can Fite Biopharma is currently generating about 0.05 per unit of risk. If you would invest  368.00  in Collplant Biotechnologies on September 1, 2024 and sell it today you would earn a total of  80.00  from holding Collplant Biotechnologies or generate 21.74% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Collplant Biotechnologies  vs.  Can Fite Biopharma

 Performance 
       Timeline  
Collplant Biotechnologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Collplant Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Can Fite Biopharma 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Can Fite Biopharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Can Fite is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Collplant Biotechnologies and Can Fite Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Collplant Biotechnologies and Can Fite

The main advantage of trading using opposite Collplant Biotechnologies and Can Fite positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Collplant Biotechnologies position performs unexpectedly, Can Fite can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Can Fite will offset losses from the drop in Can Fite's long position.
The idea behind Collplant Biotechnologies and Can Fite Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stocks Directory
Find actively traded stocks across global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like